Non-linear associations of body mass index with impaired fasting glucose, β-cell dysfunction, and insulin resistance in nondiabetic Chinese individuals: a cross-sectional study
, 3, 4, 1, 1, 1
Abstract
Introduction: Identifying and managing patients with prediabetes is important. The study aims to investigate the association of body mass index (BMI) with impaired fasting glucose (IFG), β-cell dysfunction, and insulin resistance in nondiabetic Chinese individuals.
Material and methods: This was a cross-sectional study of consecutive nondiabetic individuals enrolled between January 2014 and January 2015, divided into NFG [normal fasting glucose, fasting blood glucose (FBG) < 5.6 mmol/L) and IFG (n = 450; FBG ≥ 5.6 mmol/L) groups. Restricted cubic splines and piecewise-regression were used to model the association of IFG, impaired b-cell function, and insulin resistance with BMI. Stratified analyses were performed across sex and age.
Results: A total of 900 NFG and 450 IFG individuals were enrolled, with a median age of 41 (30–49) years and 1076 males (79.7%). After adjusting for age and sex, the restricted cubic splines showed that the risk of IFG was increasing rapidly until around 27.96 kg/m2 of BMI and then started to plateau afterward (p for non-linearity = 0.010), which was similar in males and individuals ≤ 45 years old (p for nonlinearity < 0.001 and = 0.007, respectively). The risk of insulin resistance increased and β-cell dysfunction decreased as the BMI increased in all participants (both p for non-linearity > 0.05), consistent with the results in males, females, and ≤ 45 and > 45 year olds.
Conclusions: The risk of IFG does not rise linearly as the BMI increases, and higher BMI seems to decelerate the rise of the risk.
Keywords: insulin-secreting cellsinsulin resistanceblood glucosebody mass index
References
- Zhang DD, Tang X, Jin DY, et al. [Prevalence of diabetes in Chinese adults: a Meta-analysis]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018; 39(6): 852–857.
- Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017; 317(24): 2515–2523.
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37 Suppl 1: S81–S90.
- Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9): 829–841.
- Ma RC, Lin Xu, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol. 2014; 2(12): 980–991.
- Wilcox G. Insulin and insulin resistance. Clin Biochem Rev . 2005; 26(2): 19–39.
- Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001; 86(9): 4047–4058.
- Matthews DR, Cull CA, Stratton IM, et al. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med. 1998; 15(4): 297–303, doi: 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W.
- DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015; 1: 15019.
- Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6): 1487–1495.
- Chen G, Liu C, Yao J, et al. Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China. Metabolism. 2010; 59(12): 1823–1832.
- Bi Y, Zhu D, Jing Y, et al. Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese. Acta Diabetol. 2012; 49 Suppl 1: S51–S58.
- Cerf ME, Cerf ME, Chapman CS, et al. High-fat programming of hyperglycemia, hyperinsulinemia, insulin resistance, hyperleptinemia, and altered islet architecture in 3-month-old wistar rats. ISRN Endocrinol. 2012; 2012: 627270.
- Pang C, Bao Yq, Wang C, et al. Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes. Chin Med J. 2008; 121(21): 2119–2123.
- Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379(9833): 2279–2290.
- Genuth S, Alberti KG, Bennett P, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26(11): 3160–3167.
- Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018; 15(1): 1–29.
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7): 539–553, doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
- Cobelli C, Toffolo GM, Dalla Man C, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007; 293(1): E1–E15.
- Liu LL, Lawrence JM, Davis C, et al. SEARCH for Diabetes in Youth Study Group. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes. 2010; 11(1): 4–11.
- Calanna S, Scicali R, Di Pino A, et al. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. Acta Diabetol. 2014; 51(4): 567–575.
- Shashaj B, Luciano R, Contoli B, et al. Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol. 2016; 53(2): 251–260.
- Bi Y, Zeng L, Zhu D, et al. Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diabetes Obes Metab. 2012; 14(2): 174–180.
- Mitsui R, Fukushima M, Nishi Y, et al. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism. 2006; 55(1): 53–58.
- Sun M, Huang X, Jiang L, et al. Characterization of β-cell function and insulin resistance in overweight Chinese adolescents with normal glucose tolerance. Exp Ther Med. 2013; 6(2): 547–551.
- Aguayo-Mazzucato C. Functional changes in beta cells during ageing and senescence. Diabetologia. 2020; 63(10): 2022–2029.
- De Tata V. Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne). 2014; 5: 138.
- Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020; 63(3): 453–461.
- Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016; 37(3): 278–316.
- Khetan AK, Rajagopalan S. Prediabetes. Can J Cardiol. 2018; 34(5): 615–623.
- Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009; 58(4): 773–795.
- Cho JH, Kim JW, Shin JA, et al. β-cell mass in people with type 2 diabetes. J Diabetes Investig. 2011; 2(1): 6–17.
- Zhang L, Qiao Q, Tuomilehto J, et al. DECODE/DECODA Study Group. Distinct ethnic differences in lipid profiles across glucose categories. J Clin Endocrinol Metab. 2010; 95(4): 1793–1801.
